Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Pharmaceutical Business Review
Return to: PBR Home | Companies

GW Pharmaceuticals Plc

GW Pharmaceuticals Plc
Sovereign House
Vision Park, Histon
Cambridge
United Kingdom
Phone: 44 1223 266800
Fax: 441-22-3235667
www.gwpharm.com

No. employees: 429
Turnover: 13.94 (US$m)
Financial year end: September

Company Overview

Top Competitors


Key Employees

Adam George

Company Secretary, Director, Managing Director - UK, Executive Board

Christopher John Tovey

Chief Operating Officer, Director, Executive Board

Justin Gover

Director, Chief Executive Officer, Executive Board

Geoffrey Guy

Chairman, Executive Board

Julian Gangolli

Director, President - North America, Executive Board

Cabot Brown

Director, Non Executive Board

James Noble

Deputy Chairman, Director, Non Executive Board

Tom Lynch

Director, Non Executive Board

Scott Giacobello

Chief Financial Officer, Senior Management

Volker Knappertz, M.D.

Chief Medical Officer, Senior Management

Ben Whalley

Head - Discovery Research, Senior Management

Locations/Subsidiaries


Sovereign House,
Vision Park, Histon,
Cambridge,
Cambridgeshire,
United Kingdom
Phone: 44 1223 266800
Fax: 44 1223 235667

1 Cavendish place,
London,
England,
United Kingdom
Phone: 44 20 72910555
Fax: 44 20 72910550

Cannabinoid Research Institute Limited

England,
United Kingdom

G-Pharm Limited

England,
United Kingdom

Guernsey Pharmaceuticals Limited

Guernsey,
United Kingdom

GW Pharma Limited

England,
United Kingdom

GW Research Ltd

England,
United Kingdom

GWP Trustee Company Limited

England,
United Kingdom

GW Pharmaceuticals Inc

United States of America

Products/Services


Products:

  • Sativex (Cannabinoid Medicine) - Multiple Sclerosis Spasticity
  • Product Pipeline:
  • Epidiolex:
  • Dravet Syndrome
  • Tuberous Sclerosis
  • Lennox-Gastaut Syndrome
  • Infantile Spasms
  • CBDV (GWP42006):
  • Autism Spectrum Disorders
  • Epilepsy
  • GWP42003:
  • Schizophrenia
  • GWP42003 (IV):
  • Neonatal Hypoxic-ischemic Encephalopathy
  • GWP42002 / GWP42003:
  • Glioma